NCT06969833View on ClinicalTrials.gov

Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

June 27, 2032

Study Completion Date

June 27, 2032

Conditions
Cancer of the OvaryCancer of the Fallopian TubePeritoneal Cancer
Interventions
OTHER

Constitution of a biological collection

"* Left-over tissue samples (tumor tissue of different nature) frozen and secured in paraffin, and derived from standard care, are collected at study entrance until the end of oncologic treatment.~* One blood sample of 28mL is collected at time of inclusion"

OTHER

Assessment of Quality of Life and level of anxiety/depression

Questionnaires QLQ-C30, OV-28 and HADS are completed by the patients at inclusion, after 3 and 6 cycles of systemic treatment, and every 3 months up to 2 years after inclusion

Trial Locations (1)

Unknown

RECRUITING

Centre Oscar Lambret, Lille

All Listed Sponsors
lead

Centre Oscar Lambret

OTHER

NCT06969833 - Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma | Biotech Hunter | Biotech Hunter